ArticleTheranostics2026
Meningeal macrophages regulate fibroblasts to influence meningeal lymphatic function following traumatic brain injury.
Article in Theranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating brain organoids, meningeal immunity, and glymphatic dynamics: toward modeling neuroimmune clearance and crosstalk in disease.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The meningeal lymphatic system represents a critical pathway for cerebrospinal fluid exchange, waste clearance, and immune cell trafficking in the central nervous system. Although traumatic brain injury (TBI) induces marked alterations in meningeal immune cells, their role in regulating meningeal lymphatic function under physiological and pathological conditions remains unclear. Methods: Single-cell RNA sequencing, confocal microscopy, and flow cytometry were performed to identify a distinct population of meningeal fibroblasts that secrete VEGF-C and to investigate alterations in this population following TBI. By subdural injection of clodronate liposomes and PDGF-C, the role of meningeal resident macrophages and their secreted PDGF-C in regulating meningeal lymphatic function was further examined. Results: A distinct population of meningeal fibroblasts was identified as a source of VEGF-C, whose production is regulated by meningeal macrophages through the PDGF-C/PDGFRα axis. In the early phase of TBI, depletion of resident meningeal macrophages impaired fibroblast-derived VEGF-C production. Further investigations revealed that macrophage depletion resulted in severe meningeal lymphatic dysfunction. Conversely, subdural administration of PDGF-C after TBI enhanced fibroblast-derived VEGF-C production, restored meningeal lymphatic function, alleviated neuroinflammation, and promoted myelin integrity. Conclusion: Overall, our findings emphasize that meningeal resident macrophages can regulate fibroblast-derived VEGF-C production via PDGF-C, thereby influencing meningeal lymphatic function, and thus propose a novel therapeutic strategy to enhance neurological repair after TBI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.